Cargando…
ABHD5 suppresses cancer cell anabolism through lipolysis-dependent activation of the AMPK/mTORC1 pathway
ABHD5 is an essential coactivator of ATGL, the rate-limiting triglyceride (TG) lipase in many cell types. Importantly, ABHD5 also functions as a tumor suppressor, and ABHD5 mRNA expression levels correlate with patient survival for several cancers. Nevertheless, the mechanisms involved in ABHD5-depe...
Autores principales: | Chen, Guohua, Zhou, Guoli, Lotvola, Aaron, Granneman, James G., Wang, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7949079/ https://www.ncbi.nlm.nih.gov/pubmed/33219129 http://dx.doi.org/10.1074/jbc.RA120.014682 |
Ejemplares similares
-
Molecular Basis of ABHD5 Lipolysis Activation
por: Sanders, Matthew A., et al.
Publicado: (2017) -
mTORC1 restrains adipocyte lipolysis to prevent systemic hyperlipidemia
por: Paolella, Lauren M., et al.
Publicado: (2019) -
mTORC1 beyond anabolic metabolism: Regulation of cell death
por: Zhu, Jiajun, et al.
Publicado: (2022) -
AMPK suppresses Th2 cell responses by repressing mTORC2
por: Pandit, Mahesh, et al.
Publicado: (2022) -
Neuronal mTORC1 inhibition promotes longevity without suppressing anabolic growth and reproduction in C. elegans
por: Smith, Hannah J., et al.
Publicado: (2023)